Can Advocacy Groups Provide Useful Patient-Centered Data?
A survey presented during ASCO20 found that patients who considered themselves adequately informed felt “in control” most days.
Business
Large Losses Anticipated for Primary Care Practices in 2020
Primary care practices are estimated to lose more than $67,000 in gross revenue per full-time physician over the course of 2020 due to COVID-19.
Boosting Income During the COVID-19 Crisis
Finding ways to increase patient volume and cut costs can improve practices’ bottom lines.
Back to Basics: Focus on Risk Assessments for HIPAA Compliance
Regardless of the challenges a smaller group might have, a risk assessment is a baseline for any HIPAA program. The cost of this assessment is considerably less than a HIPAA fine.
FDA: Emergency Use Authorization Revoked for Chloroquine, Hydroxychloroquine
The FDA has revoked the emergency use authorization for chloroquine phosphate and hydroxychloroquine sulfate based on emerging data suggesting that these agents are unlikely to be effective against COVID-19.
Practicing Medicine in the COVID-19 Pandemic: Doctors Adapt, Improvise
Experiences during the COVID-19 crisis could speed changes in healthcare delivery.
What To Do When Vendors Fail
NRC Health, a software and patient satisfaction survey provider holding data from more than 25 million patients, was locked out of its computer system in February because of a ransomware attack.
Tips for Getting Practices Back to Full Service
As providers begin to reopen their practices or resume the full range of services they provided before the COVID-19 pandemic, they will have to consider not only normal clinical care and regulations, but extra precautions needed for staff and patient safety, financial challenges like stimulus loan requirements, employee furloughs, and compliance with local and state regulations.
Out-of-Network Billing Common for Privately Insured Patients Receiving In-Network Care
Little is known about the frequency and financial repercussions of out-of-network billing, despite frequent news in the media about surprise medical bills.
Medicare Part D Spending: Single-Enantiomer Drugs vs Racemic Precursors
Substituting 12 single-enantiomer drugs with their racemic precursors had the potential to result in $16.6 billion of savings, with Medicare beneficiaries potentially saving $1.1 billion in out-of-pocket expense.
-
Loading...
-
Loading...
Next post in Business
